195 related articles for article (PubMed ID: 25220566)
1. Creation of a network to promote universal screening for Lynch syndrome: the LynchSyndrome Screening Network.
Mange S; Bellcross C; Cragun D; Duquette D; Gorman L; Hampel H; Jasperson K
J Genet Couns; 2015 Jun; 24(3):421-7. PubMed ID: 25220566
[TBL] [Abstract][Full Text] [Related]
2. Universal Screening for Mismatch-Repair Deficiency in Endometrial Cancers to Identify Patients With Lynch Syndrome and Lynch-like Syndrome.
Watkins JC; Yang EJ; Muto MG; Feltmate CM; Berkowitz RS; Horowitz NS; Syngal S; Yurgelun MB; Chittenden A; Hornick JL; Crum CP; Sholl LM; Howitt BE
Int J Gynecol Pathol; 2017 Mar; 36(2):115-127. PubMed ID: 27556954
[TBL] [Abstract][Full Text] [Related]
3. Comparison of two Lynch screening strategies in endometrial cancer in a California health system.
Lentz SE; Salyer CV; Dontsi M; Armstrong MA; Hoodfar E; Alvarado MM; Avila M; Nguyen NT; Powell CB
Gynecol Oncol; 2020 Jul; 158(1):158-166. PubMed ID: 32386910
[TBL] [Abstract][Full Text] [Related]
4. Implementation of tumor testing for lynch syndrome in endometrial cancers at a large academic medical center.
Moline J; Mahdi H; Yang B; Biscotti C; Roma AA; Heald B; Rose PG; Michener C; Eng C
Gynecol Oncol; 2013 Jul; 130(1):121-6. PubMed ID: 23612316
[TBL] [Abstract][Full Text] [Related]
5. Comparison of screening strategies for Lynch syndrome in patients with newly diagnosed endometrial cancer: a prospective cohort study in China.
Chao X; Li L; Wu M; Ma S; Tan X; Zhong S; Bi Y; Lang J
Cancer Commun (Lond); 2019 Jul; 39(1):42. PubMed ID: 31307542
[TBL] [Abstract][Full Text] [Related]
6. Performance characteristics of screening strategies for Lynch syndrome in unselected women with newly diagnosed endometrial cancer who have undergone universal germline mutation testing.
Ferguson SE; Aronson M; Pollett A; Eiriksson LR; Oza AM; Gallinger S; Lerner-Ellis J; Alvandi Z; Bernardini MQ; MacKay HJ; Mojtahedi G; Tone AA; Massey C; Clarke BA
Cancer; 2014 Dec; 120(24):3932-9. PubMed ID: 25081409
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Universal Versus Age-Restricted Screening of Colorectal Tumors for Lynch Syndrome Using Mismatch Repair Immunohistochemistry: A Cohort Study.
Li D; Hoodfar E; Jiang SF; Udaltsova N; Pham NP; Jodesty Y; Armstrong MA; Hung YY; Baker RJ; Postlethwaite D; Ladabaum U; Levin TR; Corley DA; Bergoffen J
Ann Intern Med; 2019 Jul; 171(1):19-26. PubMed ID: 31181578
[TBL] [Abstract][Full Text] [Related]
8. Implementing universal Lynch syndrome screening (IMPULSS): protocol for a multi-site study to identify strategies to implement, adapt, and sustain genomic medicine programs in different organizational contexts.
Rahm AK; Cragun D; Hunter JE; Epstein MM; Lowery J; Lu CY; Pawloski PA; Sharaf RN; Liang SY; Burnett-Hartman AN; Gudgeon JM; Hao J; Snyder S; Gogoi R; Ladd I; Williams MS
BMC Health Serv Res; 2018 Oct; 18(1):824. PubMed ID: 30376847
[TBL] [Abstract][Full Text] [Related]
9. Impact of an immunohistochemistry-based universal screening protocol for Lynch syndrome in endometrial cancer on genetic counseling and testing.
Frolova AI; Babb SA; Zantow E; Hagemann AR; Powell MA; Thaker PH; Gao F; Mutch DG
Gynecol Oncol; 2015 Apr; 137(1):7-13. PubMed ID: 25617771
[TBL] [Abstract][Full Text] [Related]
10. Genetic counseling and cascade genetic testing in Lynch syndrome.
Hampel H
Fam Cancer; 2016 Jul; 15(3):423-7. PubMed ID: 26969309
[TBL] [Abstract][Full Text] [Related]
11. Universal screening for Lynch syndrome among patients with colorectal cancer: patient perspectives on screening and sharing results with at-risk relatives.
Hunter JE; Arnold KA; Cook JE; Zepp J; Gilmore MJ; Rope AF; Davis JV; Bergen KM; Esterberg E; Muessig KR; Peterson SK; Syngal S; Acheson L; Wiesner G; Reiss J; Goddard KAB
Fam Cancer; 2017 Jul; 16(3):377-387. PubMed ID: 28176204
[TBL] [Abstract][Full Text] [Related]
12. Initiation of universal tumor screening for Lynch syndrome in colorectal cancer patients as a model for the implementation of genetic information into clinical oncology practice.
Cohen SA; Laurino M; Bowen DJ; Upton MP; Pritchard C; Hisama F; Jarvik G; Fichera A; Sjoding B; Bennett RL; Naylor L; Jacobson A; Burke W; Grady WM
Cancer; 2016 Feb; 122(3):393-401. PubMed ID: 26480326
[TBL] [Abstract][Full Text] [Related]
13. Assessment of Tumor Sequencing as a Replacement for Lynch Syndrome Screening and Current Molecular Tests for Patients With Colorectal Cancer.
Hampel H; Pearlman R; Beightol M; Zhao W; Jones D; Frankel WL; Goodfellow PJ; Yilmaz A; Miller K; Bacher J; Jacobson A; Paskett E; Shields PG; Goldberg RM; de la Chapelle A; Shirts BH; Pritchard CC;
JAMA Oncol; 2018 Jun; 4(6):806-813. PubMed ID: 29596542
[TBL] [Abstract][Full Text] [Related]
14. Lynch syndrome screening in newly diagnosed colorectal cancer in general pathology practice: from the revised Bethesda guidelines to a universal approach.
Morrison J; Bronner M; Leach BH; Downs-Kelly E; Goldblum JR; Liu X
Scand J Gastroenterol; 2011 Nov; 46(11):1340-8. PubMed ID: 21879804
[TBL] [Abstract][Full Text] [Related]
15. Universal screening for Lynch syndrome in endometrial cancers: frequency of germline mutations and identification of patients with Lynch-like syndrome.
Dillon JL; Gonzalez JL; DeMars L; Bloch KJ; Tafe LJ
Hum Pathol; 2017 Dec; 70():121-128. PubMed ID: 29107668
[TBL] [Abstract][Full Text] [Related]
16. Experience of the implementation and outcomes of universal testing for Lynch syndrome in the United Kingdom.
Cavazza A; Radia C; Harlow C; Monahan KJ
Colorectal Dis; 2019 Jul; 21(7):760-766. PubMed ID: 30815953
[TBL] [Abstract][Full Text] [Related]
17. The proportion of endometrial tumours associated with Lynch syndrome (PETALS): A prospective cross-sectional study.
Ryan NAJ; McMahon R; Tobi S; Snowsill T; Esquibel S; Wallace AJ; Bunstone S; Bowers N; Mosneag IE; Kitson SJ; O'Flynn H; Ramchander NC; Sivalingam VN; Frayling IM; Bolton J; McVey RJ; Evans DG; Crosbie EJ
PLoS Med; 2020 Sep; 17(9):e1003263. PubMed ID: 32941469
[TBL] [Abstract][Full Text] [Related]
18. Lynch syndrome presenting as endometrial cancer.
Tafe LJ; Riggs ER; Tsongalis GJ
Clin Chem; 2014 Jan; 60(1):111-21. PubMed ID: 24193118
[TBL] [Abstract][Full Text] [Related]
19. Association of tumor morphology with mismatch-repair protein status in older endometrial cancer patients: implications for universal versus selective screening strategies for Lynch syndrome.
Rabban JT; Calkins SM; Karnezis AN; Grenert JP; Blanco A; Crawford B; Chen LM
Am J Surg Pathol; 2014 Jun; 38(6):793-800. PubMed ID: 24503759
[TBL] [Abstract][Full Text] [Related]
20. Targeted Screening With Combined Age- and Morphology-Based Criteria Enriches Detection of Lynch Syndrome in Endometrial Cancer.
Lin DI; Hecht JL
Int J Surg Pathol; 2016 Jun; 24(4):297-305. PubMed ID: 26842347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
